Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”

Detalles Bibliográficos
Autores principales: Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284090/
https://www.ncbi.nlm.nih.gov/pubmed/35838876
http://dx.doi.org/10.1007/s40264-022-01205-z
_version_ 1784747480376672256
author Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_facet Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_sort Mungmunpuntipantip, Rujittika
collection PubMed
description
format Online
Article
Text
id pubmed-9284090
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-92840902022-07-15 Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands” Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Drug Saf Letter to the Editor Springer International Publishing 2022-07-15 2022 /pmc/articles/PMC9284090/ /pubmed/35838876 http://dx.doi.org/10.1007/s40264-022-01205-z Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
title Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
title_full Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
title_fullStr Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
title_full_unstemmed Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
title_short Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
title_sort comment on “description of frequencies of reported adverse events following immunization among four different covid-19 vaccine brands”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284090/
https://www.ncbi.nlm.nih.gov/pubmed/35838876
http://dx.doi.org/10.1007/s40264-022-01205-z
work_keys_str_mv AT mungmunpuntipantiprujittika commentondescriptionoffrequenciesofreportedadverseeventsfollowingimmunizationamongfourdifferentcovid19vaccinebrands
AT wiwanitkitviroj commentondescriptionoffrequenciesofreportedadverseeventsfollowingimmunizationamongfourdifferentcovid19vaccinebrands

Ejemplares similares